Livewire Podcast

Patrick Poke at Livewire hosted us, and we talk Disney, our top picks in digital health, growth investing, and why we've been so optimistic.

I also recommend 'Billion Dollar Molecule', a mix of Barbarians at the Gate and Liar's Poker... but for pharmaceutical companies.

Available here.

From Livewire: Michael FrazisFounder and Portfolio Manager at Frazis Capital Partners, is positive about the outlook for equities. Despite the obvious challenges the world faces, a combination of monetary and fiscal stimulus, and economies that are beginning open back up, should present a perfect setup for growth equities. But that doesn’t mean investors can be blasé about what they buy. He warns that in some popular sectors, prices have gotten too high in some names.

“Even in the hottest parts of the market, where there’s companies trading on 25-35 times sales or more, there are companies trading on a tenth of that. I think it’s extraordinarily important now to dodge some of those companies.”


  • 2:57 - Michael's background and how it shaped his investing strategy

  • 5:05 - Why he's bullish and why rising interest rates are a risk

  • 8:53 - Will the bifurcation of growth and value stocks continue, or even accelerate?

  • 14:46 - Reconciling companies that consumers love but investors hate

  • 20:12 - Something 'strange' happened that caused Michael to buy Afterpay, why it's one of the most impressive businesses around, and what Tencent may be thinking of doing with it

  • 25:52 - What he sold, mistakes made and additions to the portfolio

  • 29:59 - Why the market is mispricing Disney (NYS:DIS)

  • 34:30 - Why Tesla (NAS:TSLA) reminds Michael of Apple (NAS:AAPL)

  • 37:25 - Michael responds to our three favourite questions

Books discussed:

Stocks discussed:

  • Afterpay

  • Alteryx

  • Progyny

  • Catasys

  • Livongo Health

  • Disney

  • Tesla

  • Apple



Frazis Capital Partners Pty Ltd is a corporate authorised representative (CAR No. 1263393) of Lanterne Strategic Investors Pty Ltd (AFSL No. 238198). The Frazis Fund is open to wholesale investors only, as defined in the Corporations Act 2001 (Cth). The Company is not authorised to provide financial product advice to retail clients and information on this website does not constitute financial product advice to retail clients.


The information provided on this website is for general information purposes only, and does not take into account the personal circumstances or needs of investors. The Company and its directors or employees or associates will use their endeavours to ensure that the information published on the Website is accurate as at the time of its publication.  Notwithstanding this, the Company excludes any representation or warranty as to the accuracy, reliability, or completeness of the information contained on the Website.

The past results of the Company’s investment strategy do not necessarily guarantee the future performance or profitability of any investment strategies devised or suggested by the Company.

The Company, and its directors or employees or associates, do not guarantee the performance of any financial product or investment decision made in reliance of any material on this Website. The Company does not accept any loss or liability which may be suffered by a Website user as a result of any interrupted access to the Website or otherwise as a result of accessing the Website.